Increased sensitivity of gastric cancer cells to natural killer and lymphokine-activated killer cells by aNtisense Suppression of N-acetylgalactosaminyltransferase

Journal of Immunology

Volumn 159, Issue 6, 1997, Pages 2645-2651

  Adachi, Takeya ^a   Hinoda, Yuji ^a   Nishimori, Isao ^b   Adachi, Masaaki ^a   Imai, Kohzoh ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; N ACETYLGALACTOSAMINYLTRANSFERASE;

ANIMAL; ARTICLE; CANCER TRANSPLANTATION; COLON TUMOR; CYTOTOXICITY; DRUG ANTAGONISM; EXPERIMENTAL NEOPLASM; GENETIC TRANSFECTION; GENETICS; HUMAN; IMMUNOLOGY; LYMPHOKINE ACTIVATED KILLER CELL; MOUSE; PATHOLOGY; STOMACH TUMOR;

ANIMALS; COLONIC NEOPLASMS; CYTOTOXICITY, IMMUNOLOGIC; HUMANS; KILLER CELLS, LYMPHOKINE-ACTIVATED; MICE; N-ACETYLGALACTOSAMINYLTRANSFERASES; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; OLIGONUCLEOTIDES, ANTISENSE; STOMACH NEOPLASMS; TRANSFECTION;

EID: 0031571810     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Jentofi, N. 1990. Why are proteins O-glycosylated? Trends Biochim. Sci. 15:291.
2. Kozarsky, K., D. Kingsley, and M. Krieger. 1988. Use of a mutant cell line to study the kinetics and function of O-linked glycosylation of low density lipoprotein receptors. Proc. Natl. Acad. Sci. USA 85:4335.
3. Codington, J. F., and S. Haavik. 1992. Epiglycanin: a carcinoma-specific mucintype glycoprotein of the mouse TA3 tumor. Glycobiology 2:173.
4. Sherblom, A. P., and C. E. Moody. 1986. Cell surface sialomucin and resistance to natural cell-mediated cytotoxicity of rat mammary tumor ascites cells. Cancer Res. 46:4543.
5. Steck, P. A., and G. L. Nicolson. 1983. Cell surface glycoproteins of 13762NF mammary adenocarcinoma clones of differing metastatic potentials. Exp. Cell Res. 147:255.
6. Ligtenberg, M. J. L., F. Buijs, H. L. Vos, and J. Hilkens. 1992. Suppression of cellular aggregation by high levels of episialin. Cancer Res. 52:2318.
7. Makiguchi, Y., Y. Hinoda, and K. Imai. 1996. Effect of MUC1 mucin, an anti-adhesion molecule, on tumor cell growth. Jpn. J. Cancer Res. 87:505.
8. van de Wiel-van Kemenade, E., M. J. L. Ligtenberg, A. J. de Boer, F. Buijs, H. L. Vos, C. J. Melief, J. Hilkens, and C. G. Figdor. 1993. Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction. J. Immunol. 151:767.
9. Shogren, R., T. A. Gerken, and N. Jentoft. 1989. Role of glycosylation on the conformation and chain dimensions of O-linked glycoproteins: light-scattering studies of ovine submaxillary mucin. Biochemistry 28:5525.
10. Shogren, R. L., N. Jentoft, T. A. Gerken, A. M. Jamieson, and J. Blackwell. 1987. Light-scattering studies of fractionated ovine submaxillary mucins. Carbohydr. Res. 160:317.
11. Gerken, T. A., K. J. Butenhhof, and R. Shogren. 1989. Effects of glycosylation on the conformation and dynamics of O-linked glycoproteins: carbon-13 NMR studies of ovine submaxillary mucin. Biochemistry 28:5536.
12. Hilkens, J., M. J. L. Ligtenberg, H. L. Vos, and S. V. Litinov. 1992. Cell membrane-associated mucins and their adhesion-modulating property. Trends Biochem. Sci. 17:359.
13. Mannori, G., P. Crottet, O. Cecconi, K. Hanasaki, A. Aruffo, R. M. Nelson, A. Varki, and M. P. Bevilacqua. 1995. Differential colon cancer cell adhesion to E-, P-, and L-selectin: role of mucin-type glycoproteins. Cancer Res. 55:4425.
14. Burchell, J., and J. Taylor-Papadimitriou. 1993. Effect of modification of carbohydrate side chains on the reactivity of antibodies with core-protein epitopes of the MUC1 gene product. Epithelial Cell. Biol. 2:155.
15. Magarian-Blander, J., N. Domenech, and O. J. Finn. 1993. Specific and effective T-cell recognition of cells transfected with a truncated human mucin cDNA./Ann. N.Y. Acad. Sci. 690:231.
16. Schwartz, B., R. S. Bresalier, and Y. S. Kim. 1992. The role of mucin in colon-cancer metastasis. Int. J. Cancer 52:60.